Invesco Ltd. (NYSE: IVZ) — A Twice-Broken Asset Manager Re-Rated on One Trillion Dollars of Someone Else’s Index

⚡ Claude’s Take

This is the author’s own independent opinion and general information, not investment advice. The analytical body below takes no position and sets no price target; this opening view is the single exception.

Verdict: HOLD / AVOID-here — a genuinely de-risked, better-run business whose entire good-news cycle is already in the price at a richest-ever multiple. Fair-value zone ~$23–27 (≈10–12x ~$2.20–2.30 normalized adjusted EPS plus a ~2.8% yield); not a short, given eleven straight quarters of inflows, a cleaned-up balance sheet and a hard-charging buyback. Conviction: medium.

Invesco in mid-2026 is a much healthier company than the one that traded at $12 fifteen months ago, and the market has noticed — violently. The stock has nearly doubled off its April-2025 tariff-crash low of ~$12 to ~$30.30, a fresh five-year high above even its 2021 post-COVID peak. The re-rating rests on three real things: (1) the December-2025 reorganization of the Invesco QQQ Trust into a fee-earning open-end structure, which let Invesco charge a management fee on ~$400B of AUM for the first time (~$160M/year of nearly-all-incremental-margin revenue) and lifted the adjusted operating margin to 34.5% with management guiding to the “high-30s”; (2) a balance-sheet cleanup — the $4.0B MassMutual perpetual preferred is being ground down ($500M repurchased in December 2025, a $500M senior note redeemed in January 2026), removing the equity overhang that capped the stock for six years; and (3) eleven consecutive quarters of net long-term inflows (4% organic in Q1’26), led by a genuinely hard-to-replicate China JV (record $142B, +31% organic), EMEA/APAC, ETFs and fixed income. This is the right kind of improvement, and it is real.

But at ~$30 you are paying ~13x forward adjusted EPS and the 96th percentile of Invesco’s own ten-year valuation range (99.9th on price/sales, 93rd on price/book) for a business whose one genuine franchise — the QQQ — just had its regulatory monopoly cracked: on April 6, 2026 Nasdaq ended twenty-five years of QQQ exclusivity and licensed the Nasdaq-100 to BlackRock (IQQ) and State Street (QNDX) — not minnows, but the two most powerful ETF distributors on earth. Management’s rebuttal (installed base, tax-driven switching costs, brand, tight spreads) is fair and probably right for the back book — but the forward-growth algorithm on Invesco’s crown jewel is now, at the margin, worse than it was, at exactly the moment the multiple assumes it is better. Strip out the QQQ halo and you still own a structurally-challenged, high-beta (β~1.5) traditional active manager whose fundamental-equity core is still in net outflow, whose tangible book is negative (the entire equity is acquisition goodwill and intangibles, ~$3B of the intangible piece — the acquired Oppenheimer fund-management contracts — already written off in two impairments), and whose earnings are levered to a stock market sitting at record highs. The framing is momentum / “improvement-already-priced,” not value — the identical setup to its re-rated peers Franklin, T. Rowe Price and the now-taken-private Janus Henderson. The whole group re-rated together on the same narrative; Invesco simply had the most to fix and therefore the most beta to the fix. Catchy tag: the fix is real, the price already spent it — and Nasdaq just handed the crown jewel a rival. Bullish trigger: two or three quarters proving the QQQ back book is sticky against the new competing ETFs and the net-revenue yield genuinely inflecting up (not just stabilizing) as margin marches to the high-30s — that converts a re-rate into a compounder. Bearish trigger: an equity-market drawdown (β~1.5 shreds the fee base fast) or visible QQQ/QQQM asset leakage to the cheaper new entrants, which would expose the still-melting active core at a five-year-high multiple.

📈 Stock Price Action — Five-Year Event Map

Invesco has round-tripped and then broken out. Over five years the stock fell from a ~$27 post-COVID reflation peak (2021) to a $11–12 low hit twice (October 2023 and April 2025), before nearly doubling to a fresh five-year high of ~$30.30 (July 15, 2026) — now trading above its 2021 peak. Current price ~$30.30; 52-week range ~$16.70–$30.30; the stock is at its high, ~0% off the 52-week peak and roughly +87% over the trailing twelve months. Beta is high (~1.5), so each broad-market swing is amplified in the tape below.

Cycle narrative. (1) The 2021 climb rode the everything-rally to a ~$27 peak on record AUM. (2) 2022 was the reckoning shared by every asset manager — as rates spiked, both equity and fixed-income AUM fell together and the high-beta Invesco more than halved. (3) Secular active-equity redemptions and China/regional-bank stress capped every 2023 bounce, producing the ~$12.76 five-year low in October 2023. (4) 2024 delivered a partial recovery as markets healed and flows improved. (5) The April-2025 tariff shock drove a second visit to the ~$12 low — β~1.5 meant Invesco fell harder than the market. (6–8) From mid-2025 the stock roughly doubled: the QQQ Trust fee-reorganization (Dec 20, 2025), the resulting margin jump to the mid-30s, the systematic paydown of the MassMutual preferred, an accelerating buyback ($1B authorized Feb 2026), and AUM cresting $2.47 trillion at June 2026 combined with a strong broad tape to carry the stock to ~$30.30. The price move is Fact; the attribution to those catalysts is Interpretation.

1. Executive Summary

Invesco Ltd. is a global, multi-asset, multi-vehicle investment manager with ~$2.47 trillion of AUM (June 30, 2026) spanning active and passive equities, fixed income, ETFs, private markets, and money-market funds, sold across the Americas, EMEA and Asia-Pacific to both retail/wealth and institutional channels. It is a mid-tier scale player in a structurally challenged industry — traditional active management is losing share and fee rate to passive/ETF and, at the other end of the barbell, to private markets — and Invesco has spent the last decade acquiring its way to scale (Van Kampen 2010, Guggenheim ETF 2018, OppenheimerFunds 2019) with mediocre returns on the capital deployed. The OppenheimerFunds deal has since generated ~$3.0B of impairments of indefinite-lived intangibles — the acquired mutual-fund management contracts, written down in 2023 and 2025 (goodwill itself was not impaired) — leaving GAAP earnings deeply negative in three of the last five years and tangible common equity below zero.

The investable fact of 2025–26 is a genuine, cyclical improvement in a structurally weak business. The QQQ Trust reorganization (December 2025) converted one of the world’s largest and most-traded ETFs into a fee-earning vehicle, adding ~$400B of average fee-paying AUM and driving the adjusted operating margin to 34.5% (target: high-30s) with 500bps of operating leverage. The balance sheet is being repaired — the $4.0B MassMutual preferred is being systematically retired and parent leverage is falling. Flows are positive — Q1’26 was the eleventh straight quarter of net long-term inflows (+4% organic), powered by a hard-to-replicate China JV (+31% organic), EMEA/APAC, ETFs, fixed income and SMAs, while the legacy fundamental-equity book keeps bleeding (though at its slowest pace in nine years). Cash generation is real: ~$1.4–1.5B of operating/free cash flow annually funds a ~2.8%-yield dividend and a re-started buyback (60% total-payout target).

The market has fully absorbed this. At ~$30.30 the stock trades at ~13x forward adjusted EPS (~$2.2–2.3 run-rate), ~1.1–1.4x book (all of which is goodwill), and its richest composite valuation percentile in a decade (96.6th own-history). Meanwhile the single genuine franchise — the QQQ — faces a newly-cracked index-license monopoly as Nasdaq admits BlackRock and State Street to the Nasdaq-100 in 2026. This memo takes no position and sets no price target (the sole exception is the author’s opening view above); it lays out the franchise, the moat (and its limits), the numbers, and the embedded expectations, and leaves the judgment to the reader.

2. Business Overview

Invesco is a global, independent investment manager with ~$2.47 trillion of AUM (June 30, 2026), earning the bulk of its revenue as asset-based management fees — a fee rate applied to AUM — supplemented by service/distribution fees, performance fees (small) and a modest amount of net interest. The economically meaningful top line is net revenue of ~$5.2B (~$1.3B/quarter); reported GAAP revenue of ~$6.4B is grossed up by ~$1.9B of third-party distribution and service fees that pass through to intermediaries. Revenue is recurring and AUM-linked, which makes it both sticky (clients don’t move daily) and market-sensitive (the fee base marks to market).

By vehicle/capability (AUM at 12/31/2025, period-end ~$2,170B; ~$2.47T by 6/30/2026), Invesco is a barbell straddling every part of the industry — and is now nearly half passive by assets:

• ETFs & index (~$630B) plus the QQQ (~$407B) ≈ 48% of total AUM. The flagship Invesco QQQ Trust tracks the Nasdaq-100; its lower-fee sibling QQQM (~$101B, 15bps) targets buy-and-hold retail; the broader “innovation suite” ecosystem is ~$550B, alongside S&P 500/quality/momentum products, BulletShares bond ETFs (~$27.6B), and a fast-growing active-ETF platform (~$20B, ~$35B incl. index strategies).
• Fundamental fixed income (~$311B): a scaled, growing capability (investment-grade, SMAs), a core forward priority; fixed-income flows across all vehicles were ~$14B in Q1’26.
• Fundamental equities (~$298B): the legacy active core, structurally in net outflow (−$21.1B in FY2025; −$2.4B in Q1’26, the smallest in ~9 years), though pockets (Japan Global Equity Income, US value) are inflowing.
• China JV (Invesco Great Wall, ~$132B at year-end, a record ~$142B by Q1’26): the single fastest-growing unit (+31% annualized organic), driven by Fixed-Income-Plus (balanced) products — a genuinely hard-to-replicate onshore Chinese platform.
• Global liquidity / money market (~$190B): a stabilizer that inflows in risk-off quarters.
• Private markets & multi-asset: real-estate debt/equity, broadly-syndicated loans, CLOs and disciplined direct lending (explicitly not BDC), institutional quant strategies, and a ~$37B SMA platform (+19% organic) riding the US personalization/tax-optimization wave — plus new wealth/DC vehicles seeded by the Barings and LGT partnerships.

Performance fees are negligible (~$41.5M, ~0.7% of net revenue) — this is a management-fee business, not a carry business.

The QQQ economics — the crux of the story, and the reason for this memo’s title. The Invesco QQQ Trust is ~$407B — roughly 19% of Invesco’s entire AUM — yet it contributes only an estimated 3–4% of net revenue. For most of its life QQQ was structured as a unit investment trust (UIT) under which Invesco earned essentially no management fee at all — just a Nasdaq licensing/marketing arrangement — while spending heavily to market an index it does not own (Nasdaq’s). That is the literal sense of “one trillion dollars of someone else’s index”: the ETF/QQQ complex crossed ~$1T of AUM while throwing off a thin slice of fee. The December 20, 2025 reorganization converted QQQ to an open-end fund (expense ratio 20bps→18bps) and let Invesco charge a management fee for the first time — but of the 18bps, an estimated ~14bps still covers Nasdaq-100 licensing, administration, custody and marketing, leaving only ~4bps (~$160M/year on ~$400B) to Invesco. That ~$160M is what drove the reported margin/EPS step-up — it is nearly all incremental margin (QQQ costs Invesco little to run) and was reinforced by the marketing reclassification and operating leverage elsewhere (Q1’26 management fees rose ~$152.8M YoY, primarily the new QQQ fee). But the crucial point stands: even after monetization, QQQ is a huge-AUM, tiny-revenue asset. The lower-fee sibling QQQM (~$101B, 15bps) is the higher-margin buy-and-hold vehicle and has grown without cannibalizing QQQ’s trading franchise. The strategic vulnerability is now stark: the reorg raised the economic stakes of the QQQ at the very moment Nasdaq opened the index to BlackRock and State Street — Invesco monetized the crown jewel just as its 25-year exclusivity ended.

By channel, Invesco is ~70% retail/wealth and ~30% institutional (institutional organic growth >5% for five straight quarters). By geography, it is unusually international for a US-headquartered manager: Americas ~69%, EMEA ~16%, APAC ~15% — i.e., ~31% (~$670–700B) outside the Americas, with a decades-old, “never-left-the-market” presence in China, Japan, Southeast Asia, the UK and Europe. That international tilt is a genuine differentiator versus US-centric peers and the source of the best organic growth (EMEA +8%, APAC +17% annualized in Q1’26), but it also concentrates the growth story in China and in currency-and-regulation-sensitive markets.

Strategy and leadership. CEO Andrew Schlossberg (since mid-2023) and CFO Allison Dukes have pursued a coherent “simplify, focus, monetize” agenda: divest non-core units (Intelliflo, India JV stake, Canada sub-advisory), consolidate to single global platforms (one fixed-income, one equity, one private-markets platform), monetize the QQQ, repair the balance sheet, and lean into the four secular vectors they name repeatedly — personalization (ETF/SMA/models), income, Asia/EMEA “money in motion,” and private markets into wealth/DC. It is a credible, disciplined plan; the question the rest of this memo presses is whether executing it well is enough to out-run the structural tide and justify a decade-high multiple. Verdict: a diversified, genuinely global, multi-vehicle platform — but a conglomerate of mostly-average parts anchored by one exceptional asset (QQQ, whose economics are thin) and one exceptional geography (China/APAC).

3. Industry Dynamics

Traditional asset management is a structurally deteriorating industry for the incumbents caught in the middle, and Invesco sits squarely there. The defining dynamic of the last fifteen years is the barbell: assets and economics have migrated to (a) ultra-low-cost passive/ETF scale players (Vanguard, BlackRock, State Street) and (b) high-fee private markets/alternatives (Blackstone, Apollo, KKR), hollowing out the active public-markets mutual-fund middle where Invesco’s legacy franchise lives. The consequences are relentless fee compression (the industry blended fee rate has fallen for over a decade) and share loss in active equity.

There is a subtler industry-structure point the QQQ episode illuminates: in index/ETF investing, the durable economics increasingly accrue to the index owner and the largest-scale distributor, not the fund sponsor. Nasdaq owns the Nasdaq-100 and collects a licensing fee from every ETF that tracks it — QQQ, and now BlackRock’s and State Street’s — regardless of who wins the assets. The sponsor’s economics come from scale and distribution, which is exactly where the passive oligopoly (iShares, Vanguard, State Street) has an unassailable edge. Invesco’s QQQ is a rare case of a non-oligopoly sponsor holding a scaled, branded index-ETF franchise — but the April-2026 licensing change is the index owner commoditizing the sponsor layer, inviting the scaled distributors in. It is a live example of the capital cycle grinding an above-normal-return niche back toward the mean.

Applying the Greenwald barriers-to-entry lens: public-markets active management has weak structural barriers. There is no supply/cost advantage (talent is mobile, data commoditized), demand-side captivity is low (fund switching is easy and cheap), and economies of scale are real but shared by the giants, not proprietary to a mid-tier player. The one place genuine barriers exist is at the passive scale extreme (Vanguard/BlackRock’s cost-per-dollar advantage is nearly unassailable) and in specific branded/liquidity-anchored products — which is exactly why the QQQ, not the active book, is Invesco’s only defensible asset.

Through the Marathon capital-cycle lens, the industry is a cautionary tale: high historical returns on active management attracted enormous capital and competition (indexers, robo-advisers, direct-indexing/SMAs), driving returns on incremental capital down and forcing a decade of consolidation (Invesco/Oppenheimer, Franklin/Legg Mason, Janus/Henderson, and the 2026 take-private of Janus Henderson). The supply of low-cost substitutes keeps expanding while the profit pool per dollar shrinks. There are two genuinely growing sub-pools — active ETFs/personalization (US) and Asian/Chinese onshore wealth — and Invesco is credibly positioned in both.

The fee-compression arithmetic is the industry’s central fact. Invesco’s own blended net-revenue yield has ground down from ~28.4bps (2023) to ~25.4bps (2024) to ~23.0bps (2025) — structurally below pure-active peers (Franklin ~40bps, T. Rowe ~39bps, Janus Henderson ~48bps) precisely because Invesco’s book is nearly half passive. The mix shifted from high-fee fundamental equity (often 40–70bps) toward low-fee ETFs/index (single-digit-to-low-double-digit bps for passive), fixed income, and China products. Every dollar that moves from an active equity fund to a passive ETF can lose 80–90% of its fee rate even when the asset is retained — which is why Invesco can report positive asset flows and simultaneous revenue pressure. The one encouraging 2026 development is that management flagged the yield “approaching a degree of stabilization or an inflection point,” helped by the QQQ reclassification and by higher-fee wins (Japan Global Equity Income, SMAs). Whether that is a genuine floor or a pause is the swing variable. Structurally, though, the direction of travel — passive share still rising, private markets still taking the high-fee share Invesco is under-weight — is unfavorable. Verdict: a structurally bad industry for undifferentiated active scale, with two attractive sub-pools (active-ETF/personalization and Asia) where Invesco has real, if contested, positions.

4. Competitive Position

Does Invesco have a moat? Narrowly — in exactly one product and one geography, and both are contested.

The QQQ is the one genuine franchise-level moat, and its mechanism is not the index (Nasdaq owns that) but the ecosystem around it: 25+ years of brand recognition, the deepest liquidity and tightest bid-ask spreads of any Nasdaq-100 vehicle, a vast options/derivatives market built on it, an entrenched institutional-and-retail installed base, and — critically — tax-driven switching costs (long-term holders sitting on large embedded gains cannot move without realizing them). Management’s own natural experiment supports this: launching the cheaper QQQM did not cannibalize QQQ but expanded the ecosystem. However, the moat just narrowed in a concrete way. On April 6, 2026, Nasdaq ended Invesco’s ~25-year de-facto exclusivity on US-listed Nasdaq-100 ETFs, licensing the index to BlackRock (IQQ) and State Street (QNDX) — the two firms with the distribution scale to actually contest it. The back book is genuinely sticky (tax, liquidity, brand); the forward flow into the Nasdaq-100 exposure is now a shared pool, and Invesco pays the same 8bps index license as its new rivals. This is the single most important competitive development in the story.

The China JV / international distribution is the second, more durable, moat: a decades-long onshore Chinese platform (Invesco Great Wall) that foreign managers cannot easily replicate (licensing, relationships, local product), plus a “never-left-the-market” APAC/EMEA franchise. This is a real, scarce asset — though it carries geopolitical and China-market risk. In Greenwald’s taxonomy, the China JV is the closest Invesco comes to genuine customer captivity plus a local economies-of-scale/regulatory barrier: the licensing regime, the onshore distribution relationships, and the incumbency of a top-tier Sino-foreign JV are barriers a new foreign entrant cannot cheaply cross. The QQQ is a demand-side advantage — habit, brand, and the switching-cost friction of embedded capital gains — rather than a supply-cost or scale barrier, which is precisely why a same-index competitor with equal scale (BlackRock) can contest the forward flow even if it cannot dislodge the back book. Everywhere else, Invesco fails all three Greenwald tests: no proprietary cost advantage, no captive customers (funds are trivially substitutable), and scale economies that accrue to the passive giants, not to a mid-tier active manager.

Run the market-share-stability test and the picture is damning for the core: Invesco’s share of the active-equity profit pool has declined for a decade (persistent net outflows), the hallmark of no moat. The share-gaining units — ETFs, China, SMAs, fixed income — are exactly the lower-fee, lower-barrier segments where share is bought with price and product, not defended by a moat. The ROIC test confirms it: through-cycle returns on the capital Invesco deployed (including the ~$3B written off) are mediocre — a business earning close to its cost of capital, not the 20%+ ROIC that signals a durable franchise.

Everywhere else, there is no moat. The fundamental-equity book competes against thousands of active funds and free index products; it is in structural outflow with easy switching and no pricing power. Against peers, Invesco is a mid-tier generalist that is subscale at both ends of the barbell: its ~$1T ETF/index platform is a fraction of iShares (~$4T+) and Vanguard (~$10T+), so it lacks the passive-scale cost moat; and its active book lacks T. Rowe’s cleaner retirement/target-date franchise and fortress balance sheet. It most resembles Franklin — a levered, goodwill-heavy roll-up straddling a shrinking active core and a growing-but-low-fee passive/alt periphery. Investment performance is respectable but not elite — and the headline is flattered by selection: management touts “~70% of active AUM beating benchmark on 5 years” (a key-capabilities subset) and 46% of funds top-quartile on 3 years, but the 10-K’s firm-wide figure is more sober — only ~44%/43%/42% of total Invesco AUM beat its benchmark on a 1/3/5-year basis at 12/31/2025. This is a middling active track record, not a performance moat. Verdict: a narrow moat confined to the QQQ ecosystem (now contested by BlackRock/State Street) and the China/APAC platform; a crowded, undifferentiated, no-moat business everywhere else.

5. Growth History and Forward Opportunities

History. Invesco’s AUM growth over the last decade has been mostly acquired, not organic — Van Kampen, Guggenheim ETF, and OppenheimerFunds each bought scale, while the organic story was a persistent active-equity bleed partly offset by ETF and international inflows. Reported (gross) revenue has actually declined from ~$6.9B (2021) to ~$6.4B (2025) as fee-rate compression and the active bleed outran market appreciation; net revenue is more stable. The genuine organic inflection is recent: firm-wide net long-term flows have turned decisively positive and accelerated — +$10.2B (2023) → +$65.1B (2024) → +$81.2B (2025) — and Q1’26 was the 11th consecutive quarter of net long-term inflows (+4% annualized organic), the longest positive streak in years. The catch, again, is composition: in 2025 the inflows were ETFs & index +$62.2B, QQQ +$23.3B, China JV +$22.8B, active fixed income +$17.1B — while fundamental equities bled −$21.1B. The high-fee bucket is the one shrinking; the growth is lower-fee. Positive asset flow, pressured revenue flow.

Forward opportunities — the credible growth vectors:

• ETFs & active ETFs / personalization (US): the ~$1T ETF platform plus a fast-scaling active-ETF and ~$37B SMA franchise ride the secular shift to tax-optimized, personalized wealth vehicles — the clearest structural tailwind Invesco has.
• Asia / China: the ~$142B China JV (+31% organic) and broader ~$700B APAC/EMEA footprint are exposed to demographic-driven “money in motion,” regulatory reform (UK), and onshore Chinese wealth formation — outsized-growth markets where Invesco is entrenched.
• Private markets into wealth/DC: real-estate debt/credit vehicles (one of the fastest wealth-channel ramps in CRE credit) plus the Barings and LGT partnerships to bring institutional alternatives into wealth and defined-contribution channels — a genuine, if early, adjacency.
• QQQ international extensions: listing QQQ-style products in Hong Kong (2025) and Japan (2026), leveraging the global brand.
• Margin self-help: the hybrid investment platform (completion end-2026) targets ~$60M+ of 2027 cost saves; operating leverage carries margin toward the high-30s.

The private-markets-into-wealth bet deserves scrutiny. The most-hyped forward vector is bringing institutional alternatives (real-estate debt/equity, direct lending, CLOs) into the wealth and defined-contribution channels via the Barings and LGT Capital partnerships. The logic is sound — wealth/DC allocations to private markets are structurally rising, and Invesco has genuine institutional real-asset/alternative-credit heritage. But the skeptic’s flags are real: (1) Invesco is late to a crowded race led by Blackstone, Apollo, KKR and Ares, who own the brand and the shelf; (2) the economics of partnering (rather than owning) the product mean Invesco shares the fee; (3) MassMutual’s Barings is the counterparty and also the exiting preferred holder — a related-party arrangement worth watching; and (4) the AUM involved (~$5B in the flagship real-estate-credit vehicle after two years) is still small relative to the ~$2.2T base. This is a credible option, not yet a needle-mover, and it will be lower-fee-per-dollar than the alternatives incumbents’ captive products.

The quality caveat. Much of the growth is lower-fee (ETFs, fixed income, China fixed-income-plus), so AUM growth outpaces revenue growth and organic revenue growth is slower than organic asset growth. The high-fee fundamental-equity book — the profit engine of the past — is still shrinking. The personalization/SMA and active-ETF vectors are the highest-quality growth (US, tax-driven, defensible-ish), the China JV the highest-growth, and private markets the most speculative. Verdict: the growth is real and finally organic, but it is lower-quality (lower-fee, mix-diluting) growth; the story is a better-diversified, lower-margin-per-dollar Invesco, not a high-fee compounder.

6. Financial Quality

The five-year financial record, read on GAAP, looks like a business in secular decline; read on adjusted/cash metrics, it looks like a business that troughed in 2023 and is inflecting. Both are partly true. The table below frames the tension:

Understanding why GAAP is so misleading is the whole game. Three distortions must be normalized before any conclusion: Three distortions must be normalized before any conclusion:

(1) GAAP earnings are impairment-wrecked; use adjusted. Invesco reported a GAAP operating loss of −$695.7M and a net loss to common of −$486.3M (−$1.07 diluted EPS) in FY2025, and a −$0.73 GAAP loss in FY2023. In both years the cause was a large non-cash impairment of indefinite-lived intangible assets — the acquired OppenheimerFunds mutual-fund management contracts — of ~$1,794.9M in 2025 and ~$1,248.9M in 2023 (cumulative ~$3,043.8M; goodwill itself, ~$8.5B, was not impaired). These are real admissions that Invesco overpaid for active U.S.-retail scale at the top of the passive-migration wave, but they are not cash and not run-rate. On the metric management and the Street actually use, FY2025 adjusted diluted EPS was $2.03 (on net revenues of ~$4,658M and a 33.4% adjusted operating margin), and Q1’26 adjusted diluted EPS was $0.57, up 30% year-over-year from $0.44 — implying a ~$2.2–2.4 annualized run-rate as the full-quarter QQQ fee benefit and operating leverage build. FY2024 (also a clean year) produced $774.8M of GAAP net income. The GAAP P/E is therefore meaningless (negative); the honest lens is ~13x forward adjusted earnings and ~9–10x price-to-free-cash-flow.

(2) Gross revenue overstates the business; use net revenue. GAAP revenue of ~$6.4B (FY2025) includes ~$1.9B of third-party distribution, service and advisory fees that pass straight through to intermediaries. The economically meaningful figure is net revenue of ~$1.3B/quarter (~$5.2B annualized). On this base the adjusted operating margin is 34.5% and rising. The net revenue yield is ~22.9 basis points (Q1’26 exit 22.8bps) — and, critically, that yield has stopped falling. After years of active-to-passive/ETF mix shift compressing the blended fee rate, management flagged a “degree of stabilization or an inflection point” in Q1’26. Whether the yield merely stabilizes or genuinely re-inflects is one of the two swing variables in the thesis (the other being QQQ back-book stickiness).

(3) The balance sheet is a consolidation illusion; look through CIP/CLO. Invesco’s reported ~$9.4B of long-term borrowings is mostly non-recourse debt of consolidated investment products (CLOs and seeded funds) — matched almost dollar-for-dollar by ~$7.7B of “loans receivable” on the asset side. The parent’s recourse debt is far smaller: senior notes (~$1.5–2B after the $500M January-2026 redemption) plus ~$1.1B drawn on the revolver, against ~$1.7B of cash and a ~$2.5B remaining preferred. Net parent leverage is modest and falling — the entire capital-allocation story of 2025–26 is deleveraging. Conversely, tangible common equity is negative: ~$8.4B of goodwill plus ~$3.9B of other intangibles (~$12.3B total) exceed the ~$9.7B of common equity, leaving tangible book per share around −$4. Price-to-book (~1.1x on stated, ~1.4x on common) is therefore not a valuation floor — there are no tangible assets underneath it, only the capitalized cost of past acquisitions.

Share count, dilution and SBC. Unlike the many asset managers that quietly dilute, Invesco’s share count has been stable-to-declining — ~462M diluted shares in 2021 versus ~455M in 2025 — with stock-based compensation modest (~$80–115M/year, ~1.5–2% of net revenue) and now offset by the re-started buyback. This is a genuine positive: the per-share value creation is not being leaked away through issuance, and the new $1.0B authorization shrinks the count into rising adjusted EPS. The counter-point is that the reported equity has been eroded by the impairments and the preferred, so book-value-per-share is not a clean compounding series.

The consolidation illusion, in detail. Invesco consolidates certain CLOs and seeded funds it manages (“consolidated investment products,” CIP) even though it owns only a sliver of the economics. The mechanical result: ~$7.7B of CLO loans appear as assets and ~$9B of CLO notes appear as debt, grossing up both sides of the balance sheet and the “net debt” figure with obligations that are non-recourse to Invesco — the noteholders can look only to the CLO collateral, not to the parent. Analysts who take the ~$9.4B “total debt” or the ~$7.7B “net debt” at face value badly misjudge the leverage; the parent is close to net-cash. The same consolidation injects noise into revenue, expense and minority-interest lines and is a large part of why GAAP net income and cash flow diverge so violently year to year. The honest way to read Invesco is: net revenue, adjusted operating margin, free cash flow, and parent-only leverage — everything else is accounting exhaust.

Cash generation and returns. Despite the GAAP losses, Invesco generated ~$1,525M of operating cash flow and ~$1,441M of free cash flow in FY2025 (~$1,190M OCF in 2024), on trivial capex (~$84M). That cash comfortably covers the common dividend (~$0.84/share, ~$370M) and preferred dividends (~$205M and shrinking), leaving room for buybacks and debt paydown. Returns on capital, however, are pedestrian even in clean years: FY2024 GAAP ROE was ~7.7% and ROIC ~2.6%; the multi-year picture (impairment years included) is worse. The Marathon capital-cycle reading is unflattering: Invesco deployed ~$5.7B on OppenheimerFunds (plus Van Kampen and Guggenheim) to buy active-US-retail scale, and the return on that capital — measured honestly, i.e., including the ~$3B subsequently written off — is close to, or below, its cost of capital. A business that must impair a third of a flagship acquisition’s intangibles within six years did not earn its cost of capital on that deal. The adjusted returns look better because they exclude the impairments, which is exactly the accounting sleight the skeptic must resist: the impairments are the market’s verdict on the capital allocation, and they are real economic losses even if non-cash. This is an asset-light, cash-generative, but low-ROIC-through-the-cycle business whose economics improve with scale and market level but have never demonstrated the pricing power of a genuine compounder — the ROIC test that Greenwald and Marathon both apply comes back negative. Verdict: economics are improving cyclically and the cash is real, but through-cycle returns on the capital management has deployed are mediocre, and the reported statements flatter neither the earnings (impairments) nor the leverage (CIP) without heavy normalization.

7. Capital Allocation

Capital allocation at Invesco is a story of two managements. Prior management (the Flanagan era) was a serial value-destroyer, and current management (CEO Andrew Schlossberg since mid-2023, CFO Allison Dukes) is running a disciplined, shareholder-friendly repair — but the repair is largely undoing the prior regime’s mistakes rather than compounding new value.

The M&A legacy — bought scale at the top, wrote it off at the bottom. Invesco assembled its active US-retail scale through Van Kampen (2010), Guggenheim’s ETF unit (2018, the Source/PowerShares/BulletShares build), and OppenheimerFunds (closed May 2019, ~$5.7B all-stock). Oppenheimer was the fateful one: it was a large bet on active US-retail mutual funds struck at the very top of the passive-migration wave, and Invesco has since impaired the acquired management-contract intangibles by ~$3,043.8M (~$1,248.9M in 2023 and ~$1,794.9M in 2025). This is a textbook Marathon capital-cycle error — deploying capital into a high-return-looking area just as capital and competition (Vanguard/BlackRock passive) crushed the returns. Goodwill (~$8.5B) has so far survived impairment testing, but the intangible write-offs are the balance sheet admitting the price was wrong.

The MassMutual preferred wind-down — the standout good move. The Oppenheimer deal was part-funded with ~$4.0B of 5.9% fixed-rate non-cumulative perpetual Series A preferred issued to MassMutual (also Invesco’s largest common holder at ~18.3%, with a board seat). That perpetual, non-deductible 5.9% preferred was a ~$236M/year cash drag on common and a six-year equity overhang. In 2025 current management retired $1.5B of liquidation preference for ~$1,740M cash in two debt-funded tranches (a $1.0B repurchase at a 15% premium in April, $500M at an 18% premium in December) — paying a ~$240M premium but swapping expensive, non-deductible perpetual preferred for cheaper, tax-deductible debt. The preferred balance is down to ~$2,510.5M and the dividend run-rate has fallen from ~$236M to ~$147.5M/year, freeing ~$89M annually for common. This is genuinely accretive financial engineering and the clearest signal that management is prioritizing per-share value.

Deleveraging and the pivot to buybacks. Parent recourse debt is only ~$1,825M (a revolver draw, $500M 3.75% notes redeemed for cash in January 2026, $400M 5.375% notes due 2043, and a $500M term loan due 2030) — after the January redemption, parent debt is ~$1,325M against ~$1.0B of cash, i.e., near net-cash at the parent. (The ~$9.8B of “debt” on the consolidated screen is ~$8,968M of non-recourse consolidated CLO/CIP notes.) With the preferred shrinking, management has pivoted capital return to common: buybacks were minimal during the cleanup (~$49.6M in 2024, ~$100M in 2025) but the board approved a new $1.0B common repurchase authorization in February 2026, and management targets a ~60% total payout ratio (dividend + buyback) for 2026. The common dividend, cut in COVID, has been rebuilt to $0.21/quarter ($0.84/year, ~2.8% yield) and is covered several times over by ~$1.44B of FCF.

The capital-return math. With ~$1.44B of FCF, the priorities stack up roughly as: ~$0.37B common dividend, ~$0.15B preferred dividend (and shrinking), leaving ~$0.9B for buybacks and debt/preferred paydown. The ~60% total-payout target for 2026 implies ~$0.5–0.6B of dividends-plus-buybacks against adjusted net income, with the balance still going to finish the balance-sheet repair. The tension is real: every dollar used to retire the remaining ~$2.5B preferred (accretive, de-risking) is a dollar not buying back stock at what is now a decade-high multiple — and buying back stock at 96th-percentile valuations is a lower-return use of capital than it was at $12. A management team optimizing per-share value should arguably lean harder on preferred/debt retirement than on buybacks at this price; the ~60% payout guide suggests a balanced approach that is defensible but not obviously optimal at these levels.

Incentives are reasonable. Per the 2026 proxy, the annual incentive is 66.7% financial / 33.3% “organizational health,” and 2025 financial metrics were net long-term flows, net revenues, adjusted operating income, adjusted operating margin, and adjusted diluted EPS — appropriate, non-empire-building measures (no “grow AUM at any cost” lever). Long-term PSUs pay on relative TSR and 3-year average adjusted operating margin, capped at 100% if absolute 3-year TSR is negative — a genuine guardrail. The metrics are house-favorable non-GAAP (they exclude the very impairments and premiums that hit GAAP), but the structure rewards organic growth and relative performance rather than dilutive dealmaking.

Insider signal is neutral-to-soft. No open-market insider buying is evident; directors and officers hold ~1.4% via routine grants/vesting. The dominant “insider,” MassMutual (~18.3% + the preferred + a board seat), is being paid a premium to exit the preferred — not an independent bullish tell, though MassMutual is simultaneously deepening a commercial relationship (seeding Invesco’s Barings/LGT private-markets partnerships with ~$650M). Verdict: current management is allocating capital intelligently given the hand it was dealt — retiring expensive preferred, delevering, and starting to buy back stock — but the through-cycle record is dominated by ~$3B of prior-regime M&A write-offs, and the “repair” creates value mostly by removing prior mistakes, not by compounding.

8. Changes and Headwinds — Last Two Years

The last two years transformed Invesco’s financial profile and story:

• QQQ Trust fee-reorganization (Dec 20, 2025): the structural change that pulled ~$400B of average AUM onto the fee line, driving the margin inflection — the single biggest positive.
• Nasdaq ends QQQ exclusivity (Apr 6, 2026): BlackRock (IQQ) and State Street (QNDX) licensed to compete — the single biggest emerging headwind.
• MassMutual preferred wind-down (2025): $1.5B of the $4.0B perpetual preferred retired for ~$1.74B cash, cutting the preferred dividend run-rate by ~$89M/year and removing a six-year equity overhang.
• Balance-sheet repair: $500M senior note redeemed (Jan 2026); parent near net-cash; new $1.0B common buyback authorized (Feb 2026); ~60% total-payout target.
• Portfolio simplification: sold Intelliflo; partial sale of the India JV; Canada (CI Financial) sub-advisory transition (~$19B AUM, closing H2’26, modest near-term operating-income drag).
• Product/partnership expansion: Barings and LGT private-markets partnerships (MassMutual/Barings seeding ~$650M); QQQ Asia extensions; active-ETF and SMA launches.
• Leadership continuity: CEO Schlossberg and CFO Dukes executing a coherent repair-and-simplify agenda.
• Headwinds: structural fee compression (moderating but not over), a still-shrinking fundamental-equity core, high market sensitivity (β~1.5), China geopolitical exposure, and a decade-high valuation.

Taken together, the two-year transformation is genuinely favorable on the fundamentals and genuinely worsening on the risk/reward. Management inherited a balance sheet burdened by a $4B perpetual preferred, a stock stuck at ~$12–18, and an under-monetized crown jewel; it has retired half the preferred, delevered to near-parent-net-cash, monetized the QQQ, simplified the portfolio, and delivered eleven straight quarters of inflows and a margin inflection. That is a lot of value created — most of which the stock has now paid for, plus a premium. The single new negative — Nasdaq admitting BlackRock and State Street to the Nasdaq-100 — lands precisely on the asset the market just re-rated most. Verdict: the changes have strengthened the balance sheet and near-term earnings power decisively, but the emerging QQQ competition and the elevated multiple weaken the risk/reward from here.

9. Risk Analysis

The dominant risks are cyclical (market beta) and competitive (QQQ), not solvency. A total loss is implausible; a 40% drawdown in a market shock is entirely plausible given the beta and the elevated multiple. Three of these deserve elaboration:

Market beta is the master risk. Invesco earns a fee on a mark-to-market asset base, and its β~1.5 means its stock falls ~1.5x the market while its earnings base (AUM) falls with the market too — a double hit. The five-year chart is the proof: the stock reached ~$12 in both October 2023 and April 2025 on market shocks. At ~$30 and a decade-high multiple, the downside in a genuine bear market is larger than the current momentum suggests — the fee base, the multiple, and sentiment would compress simultaneously. This is the single most important risk and it is the one least in management’s control.

QQQ competitive erosion is a slow-fuse risk, not an overnight one. The back book is genuinely defended by embedded capital-gains taxes, liquidity and options depth, and brand — a holder sitting on years of Nasdaq-100 gains will not switch to save a basis point. But new money and institutional trading flow are contestable, and BlackRock and State Street have the distribution and the balance sheet to price aggressively and cross-sell. The risk is not that QQQ collapses; it is that its forward share of Nasdaq-100 flow — and eventually its fee — grinds lower over years, quietly removing the growth the current multiple assumes. Watch QQQ/QQQM net flows and any fee action by the entrants.

China concentration cuts both ways. The China JV is Invesco’s best growth engine (+31% organic) and a genuine competitive asset, but it also concentrates geopolitical and market risk in a single, opaque jurisdiction. A China equity-market shock, a regulatory change to the JV structure or foreign-ownership rules, or a US-China escalation affecting cross-border asset management would hit the fastest-growing, hardest-to-replace part of the platform. The same asset that differentiates Invesco from its US-centric peers is also its largest idiosyncratic tail risk.

10. Valuation Discussion (Embedded Expectations)

At ~$30.30, on ~443M shares, Invesco’s equity market capitalization is ~$13.4B. Adjusting enterprise value for the CIP illusion (stripping non-recourse consolidated debt) and adding the ~$2.5B preferred, the recourse capital structure is roughly $13.4B equity + ~$2.5B preferred + ~$1–2B net parent debt ≈ ~$17–18B of recourse enterprise value against ~$5.2B of net revenue and ~$1.8B of adjusted operating income — i.e., ~3.3–3.5x net revenue and ~10x adjusted operating income.

The multiple sits at the top of Invesco’s own decade. The AZI own-history valuation index places the stock at the 96.6th composite percentile — 99.9th on price/sales and 93rd on price/book (the P/E percentile is null on the GAAP loss). On a forward adjusted-earnings basis, ~13x is at the high end of Invesco’s historical 8–13x band; the 2020 COVID trough was 0.47x book and ~5x adjusted, and even the 2024 “clean” year traded ~1.1x book and ~12x GAAP. In other words, the re-rating has taken Invesco from decade-cheap to decade-rich in fifteen months.

Embedded-expectations read. To justify ~13x forward adjusted EPS, the market is underwriting: (a) the QQQ back book stays sticky and the fee reclassification benefit is durable, not a one-off; (b) the net-revenue yield stabilizes or inflects up rather than resuming its structural decline; © the adjusted margin marches from 34.5% toward the high-30s as guided; (d) organic growth stays positive (~4%+) as EMEA/APAC/China/ETF/SMA inflows keep outrunning the fundamental-equity bleed; and (e) the balance-sheet cleanup continues to lift equity value as preferred and debt retire. That is a coherent bull case — but it is the consensus, and it is priced. The market is not pricing a QQQ share-loss to the new competing Nasdaq-100 ETFs, a market drawdown against a β~1.5 fee base, or a resumption of active-equity outflows.

A reverse read on the ~$160M QQQ prize. It is worth sizing what the market is actually capitalizing. The QQQ reclassification adds ~$160M of net revenue at, say, an 80%+ incremental margin — call it ~$130M of pre-tax operating income, ~$100M after tax, or roughly ~$0.22 of adjusted EPS. At a 13x multiple that single accounting change is worth ~$2.85/share — nearly 10% of the entire stock price. The market has, in effect, capitalized a ~4bps fee on someone else’s index at a full active-manager multiple. That is fine while the fee is uncontested; it is precisely the cash flow BlackRock and State Street are now licensed to compete for. The asymmetry is the point: the reorg’s benefit is in the price, while the competitive risk to it is not.

Scenario framing (illustrative, no price target).

• Bear (~$18–22): an equity drawdown and/or visible QQQ/QQQM leakage takes normalized adjusted EPS toward ~$1.8–2.0 and the multiple de-rates to ~9–10x as the “improvement” narrative stalls — roughly a return toward where the stock traded in late 2025.
• Base (~$24–28): margin reaches the high-30s, flows stay modestly positive, the yield stabilizes; ~$2.2–2.4 adjusted EPS at ~11–12x plus a ~3% yield — a business fairly valued for what it is.
• Bull (~$34–40): the QQQ moat holds, the yield genuinely inflects up, high-30s margin arrives faster, and the group multiple stays elevated; ~$2.5–2.7 EPS at ~13–14x. This requires the entire consensus to be right and then some.

A sum-of-the-parts thought experiment. Because Invesco is a conglomerate of very different franchises, it is worth asking whether the parts are worth more than the ~$13.4B whole. Conceptually: the China JV (~$132–142B AUM, high-50s%-to-low-60s% margins, +31% organic) is a genuinely scarce, high-growth asset that a strategic or the JV partner might value richly — plausibly ~$3–5B; the ETF/QQQ/index complex (~$1T AUM but thin fee) is worth more for its brand and flow than its current ~$160M QQQ fee implies, but is now competitively exposed; and the fundamental-active core (~$300B equity + ~$300B fixed income) is a melting, low-multiple business worth perhaps 6–8x its share of earnings. The exercise cuts both ways: it highlights hidden value in China and the ETF brand, but also that a large slice of the enterprise is a declining active book that the blended multiple flatters. There is no obvious catalyst to crystallize a SOTP (management is a consolidator-turned-simplifier, not a break-up candidate, and MassMutual’s board presence argues for continuity), so the SOTP is a sanity check — it suggests the current price is fair rather than either deeply cheap or absurd — not an actionable gap.

Peer comparison. The whole traditional-active complex re-rated together in 2025–26; Invesco sits in the middle of the pack on multiple, at the bottom on balance-sheet quality and returns, and near the top on beta and own-history richness:

*JHG taken private; multiple struck at the buyout. The read: Invesco is not cheap relative to the group on adjusted earnings, carries the weakest balance-sheet optics (negative tangible book, a residual preferred), the highest beta, and the richest own-history multiple — yet it also has the most idiosyncratic upside optionality (the QQQ step-up, the China engine). It is priced as a full member of a re-rated cohort, not as a bargain within it. No price target; no recommendation.

11. Variant Perception

Consensus. The sell-side has largely converged on “improving but fairly valued” — price targets cluster at ~$29–33 (Barclays $31 EW, Evercore $32 IL, RBC $31 OP, Morgan Stanley $29 EW, TD Cowen $33 Buy), i.e., at or slightly below spot, with mostly Hold-equivalent ratings. Consensus believes the QQQ reclassification and margin inflection are durable and that flows stay positive, but sees limited further upside after the double.

Strongest bull case. Invesco is early in a self-help re-rating: the QQQ fee benefit is a step-change to the earnings power that is only ~two quarters into the run-rate; the hybrid-investment-platform delivers ~$60M+ of 2027 cost saves; the margin reaches the high-30s; the China/EMEA/APAC/ETF/SMA growth engines (a genuinely differentiated, hard-to-replicate international and China footprint) compound organic growth at 4–6%; the balance-sheet cleanup keeps transferring value from preferred/debt holders to common; and the buyback shrinks the share count into rising earnings. On this view ~$2.5–2.7 of EPS and a sustained group multiple support materially higher prices.

Strongest bear case. The 2025–26 move is a high-beta re-rate of a structurally-declining active manager that got the most credit for a one-time accounting reclassification. The QQQ — the only real franchise — just lost its index-license exclusivity to BlackRock and State Street, the two firms most capable of actually taking ETF share; even a slow bleed of QQQ/QQQM assets to cheaper new entrants would undercut the very engine that drove the re-rate. The fundamental-equity core is still in outflow, the net-revenue yield is still historically low and structurally pressured, tangible book is negative, and the whole thing is levered to an equity market at record highs. When the market turns, β~1.5 works in reverse, and a 96.6th-percentile multiple has one direction to go.

The 3–5 assumptions that matter most, and what falsifies each:

1. QQQ back-book stickiness — Falsified if QQQ/QQQM net flows turn persistently negative as the new Nasdaq-100 ETFs gather assets.
2. Net-revenue-yield stabilization — Falsified if the blended yield resumes a >0.5bps/quarter decline.
3. Margin path to high-30s — Falsified if adjusted operating margin stalls below ~35% despite AUM growth.
4. Organic growth stays positive — Falsified if total net long-term flows turn negative for two consecutive quarters (the inflow streak breaks).
5. Multiple durability — Falsified if the group re-rate reverses (a sector-wide de-rate from decade-high multiples).

The factor-positioning read reinforces the bear framing on positioning (not fundamentals). In a quantitative factor model Invesco is dominated by a high Market beta (~1.5–1.6 across nested models, R² ~0.55–0.64) — the tape’s single biggest driver is simply the market, amplified. Its risk-adjusted track record is a study in cyclicality: the trailing-12-month return is ~+87% (annualized Sharpe ~2.3) and the trailing-3-month figure annualizes to ~+160% (a ~+27% raw quarter) — the statistical signature of a crowded relief-rally winner, not an abandoned value name — yet the lifetime maximum drawdown is ~−80% and the five-year relative-strength is barely positive, the fingerprints of a vehicle that has round-tripped twice and can do so again. Read together: this is a stock whose recent returns are spectacular precisely because it fell so far and is so market-levered, not because a durable compounding engine was discovered. Consensus may therefore be offsides less on direction than on durability — the tape is extrapolating a cyclical, beta-driven, one-time-monetization re-rate as if it were permanent. That is the crux the bull and bear cases are really arguing about.

12. Fact vs. Interpretation

13. Open Questions

1. QQQ leakage: How much of forward Nasdaq-100 ETF flow (and eventually stock) will BlackRock’s IQQ and State Street’s QNDX capture, and at what fee? Watch QQQ/QQQM net flows over the next 3–4 quarters.
2. Yield trajectory: Is the 22.9bps net-revenue yield a true bottom, or does the ongoing active→passive/ETF/China mix shift resume the decline once the QQQ reclassification benefit laps?
3. Margin durability: Can the high-30s margin be reached and held through a flat or down market, or is it a bull-market artifact of AUM levels?
4. Fundamental-equity core: Will the legacy active-equity book ever stop bleeding, or does it structurally melt toward irrelevance (with the mix-shift implications for the blended fee)?
5. Capital return vs. deleveraging: How aggressively does management retire the remaining ~$2.5B preferred and lean into buybacks versus holding the ~60% payout — and does MassMutual’s eventual full exit create an overhang or a clearing event?
6. China concentration: How large can (and should) the China JV become as a share of earnings before the geopolitical risk outweighs the growth?

14. What Must Be True

Bull case — what must be true: (1) the QQQ back book proves genuinely sticky against BlackRock/State Street, so QQQ/QQQM net flows stay positive; (2) the net-revenue yield holds ~22.9bps or inflects up as the growth mix stabilizes; (3) adjusted margin marches to the high-30s and holds; (4) organic growth stays ~4%+ as ETF/China/APAC/SMA/fixed-income inflows outrun the active-equity bleed; and (5) the group multiple stays near decade-highs. Falsification test: two consecutive quarters of negative QQQ/QQQM net flows, OR a resumption of net-revenue-yield decline (>0.5bps/quarter), OR the inflow streak breaking — any one materially damages the bull thesis.

Bear case — what must be true: (1) new Nasdaq-100 competition visibly erodes QQQ forward flows; (2) an equity-market drawdown shrinks the β~1.5 fee base and re-exposes the melting active core; (3) the yield resumes falling as mix shift outweighs the one-time QQQ benefit; and (4) the decade-high multiple de-rates as the “improvement” narrative matures. Falsification test: QQQ/QQQM net flows stay positive through 2026–27 while adjusted margin prints the high-30s and the yield holds/rises — that would confirm the re-rate is a durable earnings step-up, not a cyclical/momentum overshoot, and break the bear case.

APPENDIX A — Standard Diligence Questionnaire

Report date 2026-07-17. Fact / Interpretation / Assumption labeled where it matters.

General

What thoughtful questions have other investors asked? (1) Is the QQQ fee reclassification a one-time step-up or the start of durable earnings growth? (2) How much of QQQ/QQQM is at risk now that Nasdaq has licensed competing Nasdaq-100 ETFs? (3) Has the net-revenue yield truly bottomed, or is stabilization temporary? (4) How much further can the balance-sheet cleanup (preferred, leverage) add to equity value? (5) Is the China JV a durable crown jewel or a geopolitical liability? (6) Can margins really reach the “high-30s”?

Cyclicality & Earnings Nature

Cyclical high or low? Interpretation: closer to a cyclical high — earnings and AUM are marked to an equity market at record levels, and adjusted EPS is inflecting up on the QQQ reclassification and operating leverage. Driven by external or internal? Both: the QQQ reorg, margin discipline and preferred paydown are internal/idiosyncratic; the AUM level and β~1.5 fee base are external/market-driven. Revenue stability: moderate — asset-based fees are recurring but mark-to-market with volatile markets; ~$5.2B net revenue. Market size/direction: global AUM is large and growing, but the active profit pool is shrinking and the fee rate structurally declining; growth is in passive/ETF, private markets, and Asia — where Invesco is mixed-to-well positioned.

Business Quality & Competitive Moat

Industry more or less competitive? More — passive scale players (Vanguard/BlackRock) and private-markets giants compress the middle where Invesco sits. Profitability (ROIC/ROE): modest — FY2024 GAAP ROE ~7.7%, ROIC ~2.6%; adjusted returns higher but through-cycle returns on deployed capital are mediocre (~$3B of M&A written off). Industry profitability / barriers: asset-light and historically profitable, but low barriers to entry against passive; the only real barriers are the QQQ’s brand/liquidity/tax-driven switching costs and Invesco’s hard-to-replicate China JV and international distribution. Easily understood? Yes at the franchise level; the statements are not (CIP consolidation, impairments, preferred). Undermined by low-cost labor? No. Do brands matter? Yes for QQQ specifically; less so for the active book. Switching costs: low for active funds; higher for QQQ (tax on realized gains) and institutional mandates.

Financial Condition & Balance Sheet

Assets not on the balance sheet? The QQQ brand/franchise and distribution relationships are not capitalized. Off-balance-sheet liabilities? Consolidated CIP/CLO obligations are on-sheet but non-recourse (~$9B) — the reverse problem: they inflate reported debt. Accounting conservatism: the intangible impairments are honest; adjusted metrics are house-favorable (exclude the impairments and the preferred-repurchase premium). CapEx-hungry? No — asset-light, ~$84M capex on ~$5.2B net revenue.

Capital Allocation & Management

FCF generation / use / philosophy: ~$1.44B FCF; used for dividend (~$370M), preferred paydown, deleveraging, and now buybacks (~60% total-payout target). Recent acquisitions? None material recently — the era of large M&A (Oppenheimer 2019) is over; current strategy is divestiture/simplification (Intelliflo, India JV partial sale, Canada/CI sub-advisory) plus product partnerships (Barings, LGT). Buying back shares? Yes, re-started — ~$100M in 2025, new $1.0B authorization Feb 2026. Issuing shares to insiders? Routine equity comp; share count roughly flat-to-down. Compensation: metrics are appropriate (flows, net revenue, adjusted margin/EPS, relative TSR with a negative-TSR cap). Management motivation: current team (Schlossberg/Dukes) is executing a credible repair-and-simplify agenda.

Valuation & Market Data

ADR/MLP/K-1? No — Invesco Ltd. is a Bermuda-domiciled company; common stock (not a K-1 issuer). Dividend policy: ~$0.84/year (~2.8% yield), rebuilt post-COVID, well covered. Profitability: adjusted operating margin 34.5% and rising; GAAP distorted by impairments. Net income vs cash from operations diverging? Yes — GAAP net loss vs ~$1.5B operating cash flow; the divergence is the non-cash impairment, so it favors cash. Use cash and adjusted earnings.

Risks & Downside

What would cause the stock to decline? An equity-market drawdown (β~1.5), visible QQQ/QQQM share loss to new Nasdaq-100 ETF entrants, a resumption of net-revenue-yield decline or active-equity outflows, a China shock, or a de-rate from the 96th-percentile multiple. Catastrophic loss risk: low — asset-light, cash-generative, near net-cash at the parent; solvency risk negligible. Total loss: implausible.

Recent News & Events

Environment changed recently? Yes: (1) the QQQ Trust fee-reorganization (Dec 2025) materially raised earnings power; (2) Nasdaq licensed two additional US-listed Nasdaq-100 ETFs (2026), cracking QQQ’s exclusivity; (3) the MassMutual preferred wind-down ($1.5B retired for ~$1.74B) de-risked the balance sheet; (4) the stock nearly doubled to a five-year high. Significant acquisitions/divestitures: divestitures/simplification (Intelliflo sold, India JV, Canada/CI sub-advisory transition ~$19B AUM closing H2’26). Accounting-policy changes: QQQ reclassification to fee earnings; retirement-eligibility comp timing change ($33M Q1’26). Other: new $1B buyback; Barings/LGT private-markets partnerships; hybrid investment platform (completion end-2026, ~$60M 2027 savings).

APPENDIX B — Source Appendix

Report date: 2026-07-17. Primary sources first. All URLs accessed 2026-07-17 unless noted.

Primary — Company Filings (SEC EDGAR, CIK 0000914208)

• Invesco Ltd. Form 10-K (FY2025) — AUM tables, revenue by type (gross vs net), intangible-asset impairment disclosure, goodwill, consolidated investment products (CIP/CLO) debt, segment/geographic mix.
• Invesco Ltd. Form 10-K (FY2021–FY2024) — five-year trend base.
• Invesco Ltd. Form 10-Q (Q1 2026, quarter ended 3/31/2026) — net revenue $1.3B, net revenue yield 22.9bps, adjusted operating margin 34.5%, parent debt/preferred detail.
• Invesco Ltd. Form 8-K filings (2024–2026) — quarterly earnings; preferred repurchase agreements (2025-04-21 $1.0B/15% premium; 2025-12-08 $500M/18% premium); $1.0B common repurchase authorization (Feb 2026); $500M 3.75% senior note redemption (Jan 2026); term-loan facility.
• Invesco Ltd. DEF 14A (proxy, filed 2026-04-02) — executive compensation metrics (net long-term flows, net revenues, adjusted operating income/margin, adjusted diluted EPS; PSU relative-TSR + 3-yr avg adjusted-margin design with negative-TSR cap), insider ownership, MassMutual relationship.
• Invesco preliminary monthly AUM release (2026-07-10) — AUM $2.47T at 6/30/2026 (+0.7% M/M).

Primary — Transcripts

• Invesco Q1 2026 earnings call (2026-04-28) — Andrew Schlossberg (CEO), Allison Dukes (CFO). Source of: $21.8B net LT inflows (11th straight quarter), 4% organic; ETF/index AUM $638B (>$1T incl QQQ); QQQ ecosystem ~$550B; China JV $142B (+31%); SMA $37B; fundamental-equity −$2.4B; net revenue yield 22.9/22.8bps; adjusted margin 34.5%; adjusted EPS $0.57; Nasdaq licensing of additional Nasdaq-100 ETFs; ~60% payout target; $1B buyback authorization; hybrid-platform cost/savings; Canada/CI and India JV; Barings/LGT partnerships.

Secondary — Market & Industry Data (reconciled to filings)

• Company financial statements & ratios (income statement, cash flow, balance sheet, profitability, enterprise value, valuation multiples, per-share data, FY2020–FY2025 + Q1’26) — reconciled to the SEC filings.
• Public market data — daily price/OHLCV history (5-yr), valuation own-history percentiles (composite 96.6th; P/S 99.9th, P/B 93rd), factor loadings/beta (β~1.5), risk-adjusted return history (12-month return +87%, Sharpe ~2.3; lifetime max drawdown ~−80%).
• Nasdaq-100 ETF licensing — Nasdaq’s April 6, 2026 decision to license the Nasdaq-100 to additional US ETF sponsors (BlackRock IQQ, State Street QNDX); public ETF AUM data (QQQM ~$97–101B).

Secondary — Peer / Industry Cross-Read

• Peer asset managers: Franklin Resources (BEN), T. Rowe Price (TROW), Janus Henderson (JHG, taken private June 2026), Ameriprise (AMP) — used for peer valuation and the sector-wide re-rating context.
• Sell-side price targets (2026-06/07): Barclays $31 (EW), Evercore $32 (IL), RBC $31 (OP), Morgan Stanley $29 (EW), TD Cowen $33 (Buy).